Zobrazeno 1 - 10
of 60
pro vyhledávání: '"G. Brent Irvine"'
Autor:
Rivka Ravid, Simon Brockbank, David T.R. Coulson, Joseph F. Quinn, Jan Hellemans, Janet A. Johnston, Nancy Beyer, G. Brent Irvine
Publikováno v:
Brain Research, 1459, 71-80. Elsevier B.V.
α-Synuclein is a neuronal protein implicated in the etiology of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Whilst increased α-synuclein expression due to gene duplication or triplication can cause familial PD, previous studies of
Autor:
David T.R. Coulson, Nancy Beyer, Simon Brockbank, Jan Hellemans, Joseph F. Quinn, Janet A. Johnston, G. Brent Irvine, Rivka Ravid
Publikováno v:
Journal of Alzheimer's Disease, 22, 1111-1122. IOS Press
β-site AβPP cleaving enzyme 1 (BACE1) catalyses the rate-limiting step for production of amyloid-β (Aβ) peptides, involved in the pathological cascade underlying Alzheimer's disease (AD). Elevated BACE1 protein levels and activity have been repor
Autor:
A. Peter Passmore, M. McConville, G. Brent Irvine, Stephen Todd, W.W. Liu, David T.R. Coulson, Bernadette McGuinness, Janet A. Johnston, David Craig
Publikováno v:
Journal of Neurochemistry. 108:341-349
Research into the cause of Alzheimer's disease (AD) has identified strong connections to cholesterol. Cholesterol and cholesterol esters can modulate amyloid precursor protein (APP) processing, thus altering production of the Abeta peptides that depo
Autor:
Jeremy T. Stone, David Gosal, Sarah Lincoln, J. Mark Gibson, Timothy Lynch, Matthew J. Farrer, Janet A. Johnston, Owen A. Ross, G. Brent Irvine, Michael G. Heckman
Publikováno v:
Mechanisms of Ageing and Development. 128:378-382
Genetic variation of the α- synuclein gene ( SNCA ) is known to cause familial parkinsonism, however the role of SNCA variants in sporadic Parkinson's disease (PD) remains elusive. The present study identifies an association of common SNCA polymorph
Autor:
G. Brent Irvine, Angela M. Bodles
Publikováno v:
Protein & Peptide Letters. 11:271-279
Alpha-synuclein is a major component of Lewy bodies in Parkinson's disease and is found associated with several other forms of dementia. As with other neurodegenerative diseases, the ability of alpha-synuclein to aggregate and form fibrillar deposits
Publikováno v:
Neuroscience Letters. 359:89-93
Alpha-synuclein has been linked to amyloidogenesis in Parkinson's disease and other neurodegenerative disorders. We have previously shown that a peptide comprising residues 68-78 of alpha-synuclein is the minimum fragment that, like alpha-synuclein i
Autor:
G. Brent Irvine
Publikováno v:
Journal of Biochemical and Biophysical Methods. 56:233-242
Gel filtration on soft gels has been employed for over 40 years for the separation, desalting and molecular weight estimation of peptides and proteins. Technical improvements have given rise to high-performance size-exclusion chromatography (HPSEC) o
Publikováno v:
Journal of Neurochemistry. 78:384-395
The non-beta-amyloid (Abeta) component of Alzheimer's disease amyloid (NAC) and its precursor alpha-synuclein have been linked to amyloidogenesis in several neurodegenerative diseases. NAC and alpha-synuclein both form beta-sheet structures upon agei
Autor:
Omar M. A. El-Agnaf, G. Brent Irvine
Publikováno v:
Journal of Structural Biology. 130:300-309
Synucleinsare small proteins that are highly expressed in brain tissue and are localised at presynaptic terminals in neurons. alpha-Synuclein has been identified as a component of intracellular fibrillar protein deposits in several neurodegenerative
Publikováno v:
European Journal of Biochemistry. 267:2186-2194
The non-Abeta component of Alzheimer's disease amyloid (NAC) and its precursor alpha-synuclein have been linked to amyloidogenesis in Alzheimer's disease (AD), Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Previously we have shown tha